Toshiba Licenses Key DNA Chip Patents to Antara
News Mar 13, 2006
Toshiba Corporation has announced that it has licensed key patents on DNA chips and DNA detection and analysis to Antara BioSciences Inc. of the United States.
The license covers the application of Toshiba-developed and patented DNA chips and electrochemical DNA analysis system to in vitro diagnosis of disease in humans within the United States.
Antara plans to develop DNA chips and diagnostic systems based on the licensed patents and guide the products through the approval procedures of the Food and Drug Administration (FDA).
Toshiba established the Business Development Office at its Corporate Research & Development Center in Kawasaki, Japan in 2001, to investigate promising new business areas.
This approach bore fruit in DNA-based diagnostics: Toshiba developed the Genelyzer™ portable, automated DNA detection system in 2003, and, in 2004, a DNA chip that was small, sensitive, and based on Complementary Metal Oxide Semiconductor (CMOS) technology, the mainstream IC technology.
Bioethics Council Rules Heritable Genome Editing "Ethically Acceptable" In Certain CircumstancesNews
A leading UK bioethics advisory body has weighed in on the debate around human genetic modification, concluding that heritable genome editing – modifying the DNA of an egg, sperm or embryo with changes that will be passed on to future generations – could be ‘morally permissible’ in humans, provided key ethical tests are met.
Genetic Factors Leading to Rare Bone Fusion Disorder IdentifiedNews
Genome sequencing establishes multiple genes responsible for a rare condition that cause bone fusionREAD MORE
Hay Fever Risk Genes Overlap with Autoimmune DiseaseNews
In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.READ MORE